TSW
CANO

Thompson Siegel & Walmsley’s Cano Health, Inc. CANO Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-550
Closed -$477K – 586
2022
Q3 		$477K Buy
+550
New +$345K 0.01% 289

Other funds holding CANO

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Thompson Siegel & Walmsley's CANO Position: Q4 2022 in Review

Thompson Siegel & Walmsley sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 550 shares — an estimated $477K sold.

Thompson Siegel & Walmsley first reported a position in CANO in Q3 2022 and held it in 1 quarter. The position peaked at $477K in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Thompson Siegel & Walmsley reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 550 Cano Health, Inc. shares in Q4 2022, an estimated $477K.
  • Thompson Siegel & Walmsley first reported a position in Cano Health, Inc. in Q3 2022 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's Cano Health, Inc. position peaked at $477K in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Thompson Siegel & Walmsley's 13F filing for Q4 2022, filed 10 Feb 2023.